Immunic, Inc. Announces Participation in Key April Conferences

Immunic, Inc., a biotechnology firm listed on Nasdaq, will engage in several notable scientific and industry conferences in April 2025. The company's management and scientific teams will be presenting at events focused on inflammatory and autoimmune disease therapies.

From April 5-9, Immunic's team will attend the American Academy of Neurology Annual Meeting in San Diego, California. On April 9-10, Chief Scientific Officer Hella Kohlhof will present at the German Biotech Days in Heidelberg, Germany. Her presentation will highlight advancements in Immunic's lead asset, vidofludimus calcium, and will be available on the company's website.

These events are significant opportunities for Immunic to share its progress and connect with the scientific community. For more details, refer to the company's event page online.